Tongxiang Lin

Tongxiang Lin

Auto-generated profile, based on publicly available information

Tongxiang Lin

Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Cell Stem Cell
Verified
Journal Article
Closed access
HZHongyan Zhou
Hongyan Zhou
SWShili Wu
Shili Wu
JJJin Young Joo
Jin Young Joo
SZSaiyong Zhu
Saiyong Zhu
DHDong Wook Han
Dong Wook Han
SDSheng Ding
Sheng Ding

26 December 2004 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
TLTongxiang Lin
Tongxiang Lin
CCConnie Chao
Connie Chao
SSShin'Ichi Saito
Shin'Ichi Saito
SMSharlyn J. Mazur
Sharlyn J. Mazur
MMMaureen E. Murphy
Maureen E. Murphy
YXYang Xu
Yang Xu

1 December 2010 in Cell Stem Cell
Verified
Journal Article
Closed access
SZSaiyong Zhu
Saiyong Zhu
WLWenlin Li
Wenlin Li
HZHongyan Zhou
Hongyan Zhou
WWWanguo Wei
Wanguo Wei
RARajesh Ambasudhan
Rajesh Ambasudhan
SDSheng Ding
Sheng Ding

18 October 2009 in Nature Methods
Verified
Journal Article
Closed access
PDF file
TLTongxiang Lin
Tongxiang Lin
RARajesh Ambasudhan
Rajesh Ambasudhan
XYXu Yuan
Xu Yuan
WLWenlin Li
Wenlin Li
SHSimon Hilcove
Simon Hilcove
SDSheng Ding
Sheng Ding

1 January 2009 in Cell Stem Cell
Verified
Journal Article
Closed access
WLWenlin Li
Wenlin Li
WWWei Wei
Wei Wei
SZSaiyong Zhu
Saiyong Zhu
JZJinliang Zhu
Jinliang Zhu
YSYan Shi
Yan Shi
SDSheng Ding
Sheng Ding

27 April 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
WLWenlin Li
Wenlin Li
WSWoong Sun
Woong Sun
Yu ZhangYu Zhang
Yu Zhang
WWWanguo Wei
Wanguo Wei
RARajesh Ambasudhan
Rajesh Ambasudhan
SDSheng Ding
Sheng Ding
Human embryonic stem cells (hESCs) hold enormous promise for regenerative medicine. Typically, hESC-based applications would require their in vitro differentiation into a desirable homogenous cell population. A major challenge of the current hESC differentiation paradigm is the inability to effectively capture and, in the long-term, stably expand primitive lineage-specific stem/precursor cells that retain broad differentiation potential and, more importantly, developmental stage-specific differentiation propensity. Here, we report synergistic inhibition of glycogen synthase kinase 3 (GSK3), transforming growth factor β (TGF-β), and Notch signaling pathways by small molecules can efficiently convert monolayer cultured hESCs into homogenous primitive neuroepithelium within 1 wk under chemically defined condition. These primitive neuroepithelia can stably self-renew in the presence of leukemia inhibitory factor, GSK3 inhibitor (CHIR99021), and TGF-β receptor inhibitor (SB431542); retain high neurogenic potential and responsiveness to instructive neural patterning cues toward midbrain and hindbrain neuronal subtypes; and exhibit in vivo integration. Our work uniformly captures and maintains primitive neural stem cells from hESCs.